Please login to the form below

White Paper for download: Explaining the price of your product

In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step.

Are you struggling to defend the price of your product?

With around 40 years’ experience in the pharmaceutical industry and over 30 years in global market access, Valid Insight’s Senior Executive Advisor, Raf De Wilde, shares his expert insight and experiences to help guide you in explaining the price of your product.

In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step.

Download now for insight into:

  • Why pharma needs to do a better job at explaining prices
  • Explaining and justifying your price internally, to your boss, and to authorities
  • How low product differentiation leads to price referencing
  • If cost-plus pricing applies
  • A value-based pricing option
  • What is entrepreneurial pricing
  • Base principles that can help define better prices
  • How to follow price finding with price implementation

Download the white paper here: https://www.validinsight.com/resource-center/explaining-the-price-of-your-product/

22nd January 2020

Share

Tags

Company Details

Valid Insight

+44 (0) 20 3750 9833

Contact Website

Address:
152-160 City Road
Kemp House
London
EC1V 2NX
United Kingdom

Latest content on this profile

Valid Insight are hiring for Consultants in Value Communication (mid to senior levels)
New role available for Consultants in Value Communication with experience in market access writing and value communication.
Valid Insight
Webinar: Maintaining market access through a pandemic, 6 months on
In this webinar, Valid Insight explore market access and how it has evolved through a pandemic over the past 6 months.
Valid Insight
Webinar: How to develop an optimal value story for your product
This webinar is part of the ongoing expert insights series run by Valid Insight
Valid Insight
Last chance to register - Webinar: How to price a pharmaceutical product during a global economic recession
How can you ensure your product achieves optimal market access during a global economic recession?
Valid Insight
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen.
Valid Insight
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative to alternative treatments for successful market access. In this blog, we summarise the reasons for negative reimbursement decisions in 2017 and discuss common pitfalls manufacturers should avoid.
Valid Insight